GlassScriptPhysician profile
Shanthi Gowrinathan
NPI 1174892087
$661.06
in general payments reported to CMS, 2019-2025
18 companies · $25.08 in 2025
The $25.08 reported for 2025 was less than what a typical Psychosomatic Medicine provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.85 · 2020: $37.66 · 2021: $310 · 2022: $49.90 · 2023: $95.15 · 2024: $71.60 · 2025: $25.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $78.70 | 2019-2023 | Hizentra |
| Takeda Pharmaceuticals U.S.A., INC. | $68.13 | 2021 | |
| Alexion Pharmaceuticals, INC. | $64.46 | 2021 | |
| Indivior INC. | $51.33 | 2024 | Sublocade |
| Alkermes, INC. | $48.31 | 2020-2021 | |
| Lilly USA, LLC | $41.82 | 2022-2023 | Amyvid |
| Medtronic, INC. | $36.67 | 2021 | |
| Neurocrine Biosciences, INC. | $36.47 | 2023 | Ingrezza, Ongentys |
| Idorsia Pharmaceuticals US INC | $35.00 | 2022-2023 | Quviviq |
| Amneal Pharmaceuticals LLC | $28.96 | 2021 | |
| Biogen, INC. | $25.55 | 2021 | |
| Novartis Pharmaceuticals Corporation | $25.08 | 2025 | |
| Scilex Pharmaceuticals INC. | $24.91 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.06 | 2020 | |
| Bausch Health US, LLC | $20.27 | 2024 | Aplenzin |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $18.68 | 2021 | |
| Xeris Pharmaceuticals, INC. | $16.68 | 2021 | |
| Acorda Therapeutics, INC | $15.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shanthi Gowrinathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.